CRIS Current Research Information System

BELLUTI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.982
AS - Asia 4.444
EU - Europa 3.940
AF - Africa 330
SA - Sud America 226
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.912
CN - Cina 1.370
SG - Singapore 1.225
GB - Regno Unito 875
VN - Vietnam 875
IT - Italia 822
DE - Germania 574
SE - Svezia 357
HK - Hong Kong 324
IN - India 240
UA - Ucraina 236
RU - Federazione Russa 231
FR - Francia 165
NL - Olanda 153
BR - Brasile 152
IE - Irlanda 132
CI - Costa d'Avorio 116
KR - Corea 97
JO - Giordania 91
ZA - Sudafrica 84
TG - Togo 70
JP - Giappone 69
BG - Bulgaria 64
EE - Estonia 61
FI - Finlandia 61
CA - Canada 49
AR - Argentina 37
ID - Indonesia 37
SC - Seychelles 32
CH - Svizzera 31
IR - Iran 30
PL - Polonia 28
AT - Austria 22
ES - Italia 22
BE - Belgio 20
GR - Grecia 19
CZ - Repubblica Ceca 18
HR - Croazia 16
MX - Messico 14
PK - Pakistan 14
EC - Ecuador 13
TR - Turchia 11
BD - Bangladesh 10
NG - Nigeria 10
EG - Egitto 8
CO - Colombia 7
LB - Libano 7
LT - Lituania 7
AU - Australia 6
IQ - Iraq 6
MY - Malesia 6
PT - Portogallo 6
CL - Cile 5
HU - Ungheria 4
KZ - Kazakistan 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BY - Bielorussia 3
DZ - Algeria 3
GT - Guatemala 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
KE - Kenya 2
KW - Kuwait 2
LK - Sri Lanka 2
NO - Norvegia 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GI - Gibilterra 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TV - Tuvalu 1
Totale 14.935
Salva come PNG Salva come JPEG
Città #
Singapore 847
Southend 755
Ashburn 607
Fairfield 583
Chandler 560
Santa Clara 352
Hong Kong 323
Woodbridge 308
Bologna 282
Seattle 277
Wilmington 274
Houston 257
Hefei 236
Dong Ket 227
Cambridge 218
Ann Arbor 193
Princeton 188
Beijing 175
Ho Chi Minh City 154
Jacksonville 153
Hanoi 147
Boardman 132
Dublin 132
Abidjan 116
New York 98
Seoul 95
Amman 91
Nanjing 81
Westminster 81
Los Angeles 78
Lomé 70
Padova 68
Dallas 66
Tokyo 65
Berlin 64
Sofia 64
Buffalo 54
Munich 54
Bremen 50
Jinan 50
San Diego 45
Saint Petersburg 43
Shenyang 42
Helsinki 40
Redondo Beach 37
Redmond 35
Milan 33
Nanchang 32
Mülheim 31
Hebei 30
Jakarta 29
Bern 28
Tianjin 27
Guangzhou 26
Bengaluru 24
Dearborn 24
Council Bluffs 23
Shanghai 23
Frankfurt am Main 22
Jiaxing 22
Nuremberg 22
Changsha 21
Medford 21
Quận Bình Thạnh 21
Olalla 20
Brussels 19
São Paulo 19
Zhengzhou 19
Mahé 18
Da Nang 17
Des Moines 17
Redwood City 17
London 16
Phoenix 16
Venezia 16
Warsaw 16
Chicago 15
Haiphong 15
Boydton 14
Falkenstein 14
Mountain View 14
Haikou 13
Biên Hòa 12
Kunming 12
Toronto 12
Turin 12
Brooklyn 11
Lappeenranta 11
Shenzhen 11
Taiyuan 11
Yubileyny 11
Düsseldorf 10
Fremont 10
Hangzhou 10
Hải Dương 10
Montreal 10
Norwalk 10
Pune 10
San Giorgio di Piano 10
Thái Nguyên 10
Totale 9.814
Salva come PNG Salva come JPEG
Nome #
1,4-dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety 321
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 284
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 234
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 230
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 222
Progettazione e sintesi di derivati benzofuranici per la malattia di Alzheimer 215
Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells 202
Analogues of the dual acetylcholinesterase inhibitor AP2238: synthesis and SAR 193
Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold 189
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 187
Benzophenones as xanthone-open model CYP11B1 inhibitors potentially useful for promoting wound healing 186
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 182
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 182
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 181
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 180
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 180
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 179
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 178
Targeting neuronal calcium channels and GSK3β for Alzheimer's disease with naturally-inspired Diels-Alder adducts 175
Cardiovascular profile of xanthone-based 1,4 dihydropyridines bearing a lidoflazine pharmacophore fragment 174
Identification of chalcone-based antileishmanial agents targeting trypanothione reductase 168
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold 167
Identification of a new tamoxifen-xanthene hybrid as pro-apoptotic anticancer agent 166
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach 161
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates 160
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 160
Interplay Between Endocannabinoid System and Neurodegeneration: Focus on Polypharmacology 159
Natural-like Chalcones with Antitumor Activity on Human MG63 Osteosarcoma Cells 158
Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment? 156
Chitosan nanoparticles for curcumin delivery: development, characterization and in-vitro studies on cancer cells 155
Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment 155
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease 155
Potent inhibition of human phosphodiesterase-5 by icariin derivatives 154
Curcumin-1,2,3-triazole conjugation for targeting the cancer apoptosis machinery. 152
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer 149
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme 147
Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment 147
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 145
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 144
Conjugation of Quinones with Natural Polyamines: Toward an Expanded Antitrypanosomatid Profile 143
Nonsteroidal Aromatase inhibitors: synthesis and evaluation of new flavone derivatives 142
Homopterocarpanes as bridged triarylethylene analogues: synthesis and antagonistic effects in human MCF-7 breast cancer cells 142
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy 141
Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors 141
Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. 138
Potent inhibition of human phosphodiesterase-5 by icariin derivatives in an enzyme assay 138
Multifaceted activity of polyciclic MDR revertant agents in drug-resistant leukemic cells: Role of the spacer 138
New derivatives of xanthenone-4-acetic acid: synthesis, pharmacological profile and effect on TNF-alpha and NO production by human immune cells 137
Multitarget Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania 136
New Coumarin derivatives as cholinergic and cannabinoid system modulators 136
In vitro studies of flavon-8-acetic acid analogues 135
Benzophenone derivatives as Inhibitors of Acetylcholinesterase 134
In vitro biological activity of new analogues of flavon-8-acetic acid 133
Multi-target-directed coumarin derivatives: hAChE and BAC1 inhibitors as potential anti-Alzheimer compounds 132
Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm 132
New potent P-glycoprotein inhibitors carrying a polycyclic scaffold 130
Studies on cytostatic and cytotoxic activity of new flavopiridol analogues 129
Multi-target strategy to address Alzheimer’s disease: Design, synthesis and biological evaluation of new tacrine-based dimers 129
Hybrid drugs for Alzheimer's disease: new indanone derivatives bearing a pharmacophoric fragment of AP2238 128
Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi 128
High-throughput screening of beta-secretase inhibitors by multiwell FRET assay 126
Design, Synthesis, and Biological and Crystallographic Evaluation of Novel Inhibitors ofPlasmodium falciparumEnoyl-ACP-reductase (PfFabI) 124
Functionalization of the chalcone scaffold for the discovery of novel lead compounds targeting fungal infections 124
Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation 124
Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target 124
Naturally Inspired Coumarin Derivatives in Alzheimer’s Disease Drug Discovery: Latest Advances and Current Challenges 123
null 123
Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach 120
Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment 119
Targeting the Bacterial Membrane with a New Polycyclic Privileged Structure: A Powerful Tool To Face Staphylococcus aureus Infections 119
Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease 118
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation 118
null 118
Curcumin derivatives as beta-secretase (BACE1) inhibitors. 117
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 116
From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold 114
Flavonoid-inspired vascular disrupting agents: Exploring flavone-8-acetic acid and derivatives in the new century 113
The first dual ChE/FAAH inhibitors: new perspectives for Alzheimer's disease? 112
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism 111
Modulation of Cytochromes P450 with Xanthone-Based Molecules: From Aromatase to Aldosterone Synthase and Steroid 11β-Hydroxylase Inhibition 110
Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update. 107
New potent inhibitors of cytochrome P450 aromatase 106
Imidazolylmethylxanthones as potent inhibitors of cytochrome P450 aromatase 106
null 105
Mono- or di-fluorinated analogues of Flavone-8-acetic acid: synthesis and in vitro biological activity 105
null 103
Modulation of Amyloid β-induced Microglia Activation and Neuronal Cell Death by Curcumin and Analogues 101
Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012) 97
Chalcone-based carbamates for Alzheimer's disease treatment 95
In vitro methods for characterizing new multi-potent compounds for Alzheimer’s disease 92
Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity 92
Tackling Alzheimer's Disease with Existing Drugs:A Promising Strategy for Bypassing Obstacles 88
Hitting drug-resistant malaria infection with triazole-linked flavonoid–chloroquine hybrid compounds 86
Prenylated Curcumin Analogues as Multipotent Tools to Tackle Alzheimer's Disease 84
null 83
Chromone-based small molecules for multistep shutdown of arachidonate pathway: Simultaneous inhibition of COX-2, 15-LOX and mPGES-1 enzymes 83
null 82
null 79
null 76
null 73
Totale 14.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021963 0 0 0 0 0 94 29 129 120 70 90 431
2021/20221.774 164 47 107 90 150 92 48 181 94 137 341 323
2022/20232.331 211 273 112 275 187 180 65 148 469 70 164 177
2023/2024745 40 99 38 89 54 212 47 42 14 35 38 37
2024/20252.604 103 366 264 135 535 128 220 76 53 184 142 398
2025/20263.009 727 548 564 456 678 36 0 0 0 0 0 0
Totale 15.307